Synapse Open Synapse
Biology

STAT+: Coming readout of Kymera eczema trial is a high-stakes moment in a bid to rival Dupixent

STAT News · · 1 min read

Investors and doctors are intensely awaiting mid-stage results of an experimental Kymera therapy positioned to rival Dupixent.

Latest from STAT News